by The global Virus Filtration Market is estimated to be valued at US$ 5.08 Bn in 2023 and is expected to exhibit a CAGR of 14.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The virus filtration market involves filtration of viruses from liquid biological manufacturing samples such as biotherapeutics, medical devices, water, and air. Virus filters help remove viruses and other contaminants from biological samples without compromising the integrity and activity of desired products such as vaccines and drugs. They are primarily used during production of biologics such as monoclonal antibodies, recombinant proteins, blood and blood products, and gene therapy vectors. Technologies involved include tangential flow filtration, depth filtration, nanofiltration, and size exclusion. Choice of technique depends on characteristics such as virus size, filtration flux required, and throughput. Advantages include high removal rates, retention of product quality, and enable use of single-use systems.
Market key trends:
The virus filtration market is expected to witness significant growth over the forecast period driven by accelerating adoption of single-use technologies by biopharma industry. Single-use filtration systems have emerged as a safer alternative to conventional stainless steel-based equipment due to advantages such as reduced risk of cross-contamination between processes. Their disposable nature also helps eliminate cleaning, sterilization and validation requirements. Growing demand for biologics has necessitated enhanced production capacities, spurring use of single-use virus filters. In addition, rising pressure on manufacturers to ensure secure and contamination-free supply chains will stimulate market expansion.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the virus filtration market is moderate. Large capital investment is required to set up manufacturing facilities to comply with regulatory standards. Bargaining power of buyers: The bargaining power of buyers in the virus filtration market is high. Pharmaceutical and biotech companies can choose from various suppliers offering virus filtration products. Bargaining power of suppliers: The bargaining power of suppliers is moderate due to the presence of a large number of raw material suppliers and availability of substitutes. Threat of new substitutes: The threat of new substitutes is low as there are limited substitutes available for virus filtration in manufacturing of biotherapeutics and vaccines. Competitive rivalry: The competition is high among the existing players due to their widespread global presence and capability to invest in research and development.
Key Takeaways
The Global Virus Filtration Market Size is expected to witness high growth, exhibiting CAGR of 14% over the forecast period, due to increasing demand for biotherapeutics and vaccines. Geographically, North America region is expected to dominate the global virus filtration market during the forecast period due to increasing biopharmaceutical research activities and presence of major pharmaceutical companies in the region. The Asia Pacific region is anticipated to exhibit the fastest growth rate owing to rising investments by biopharmaceutical companies, improving healthcare infrastructure, and presence of contract manufacturing organizations in the region.
Key players operating in the virus filtration market are Wuxi Biologics, Clean Cell Inc., Sartorius AG, Pall Corporation, Merck KgaA, Lonza Group Ltd., General Electric Company, Thermo Fischer Scientific Inc., Asahi Kasei Medical Co. Ltd., and Charles River Laboratories International Inc., among others. These players are focusing on new product launches and expansion of their manufacturing facilities globally to strengthen their market position. For instance, in August 2019, Sartorius Stedim Biotech opened its fully automated production facility for virus filtration systems and filters in Göttingen, Germany to meet the growing demand and support accelerated development timelines in biopharmaceutical manufacturing.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
